Climate change and environmental degradation are an existential threat to Europe and the world. To overcome these challenges, the European Green Deal will transform the EU into a modern, resource-efficient and competitive economy, ensuring:

  • no net emissions of greenhouse gases by 2050
  • economic growth decoupled from resource use

On June 22, 2022, the Commission adopted pioneering proposals to restore damaged ecosystems and bring nature back across Europe, from agricultural land and seas, to forests and urban environments. The Commission also proposes to reduce the use and risk of chemical pesticides by 50% by 2030. These are the flagship legislative proposals to follow the Biodiversity and Farm to Fork Strategies and will help ensure the resilience and security of food supply in the EU and across the world.

The proposal for a Nature Restoration Law is a key step in avoiding ecosystem collapse and preventing the worst impacts of climate change and biodiversity loss.

The Commission proposed the first-ever legislation that explicitly targets the restoration of Europe’s nature, to repair the 80% of European habitats that are in poor condition, and to bring back nature to all ecosystems, from forest and agricultural land to marine, freshwater and urban ecosystems. Under this proposal for a Nature Restoration Law, legally binding targets for nature restoration in different ecosystems will apply to every Member State, complementing existing laws. The aim is to cover at least 20% of the EU’s land and sea areas by 2030 with nature restoration measures, and eventually extend these to all ecosystems in need of restoration by 2050.

The European Green Deal will improve the well-being and health of citizens and future generations by providing:

  • Fresh Water, Clean Air, Healthy Soil & Biodiversity
  • Renovated, energy efficient buildings
  • Healthy & affordable food
  • Longer lasting products that can be repaired, recycled & reused

Reference:
https://ec.europa.eu/info/strategy/priorities-2019-2024/european-green-deal_en

More News
US-India Tariffs Updates
News · 01/09/2025

Donald Trump’s tariffs of 50% have come into force on most US imports from India. India’s giant generic pharmaceuticals sector and its electronics and petroleum products are exempt from the tariffs. Aluminium, steel and copper remain at 25%, but job-heavy sectors such as textiles, jewellery, seafood and leather are squarely in the line of fire.

READ MORE
ECHA publishes updated PFAS restriction proposal
News · 01/09/2025

The European Chemicals Agency (ECHA) has published the updated proposal to restrict per- and polyfluoroalkyl substances (PFAS) under the EU’s chemicals regulation, REACH. The update has been prepared by the authorities from Denmark, Germany, the Netherlands, Norway and Sweden, who submitted the initial proposal in January 2023.

READ MORE
European chemical industry laments 15% US tariff
News · 04/08/2025

Most chemicals exported from the 27 member countries of the European Union into the US will be subject to a 15% tariff on top of their selling prices under an agreement signed on July 27 between the US and the European Commission.

READ MORE
Empowering Healthcare Together – The science of biologics meets the strength of distribution
News · 01/07/2025

We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.

READ MORE
U.S. Tariffs Update – May 2025!
News · 02/06/2025

The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.

READ MORE
Major Regulatory Changes in 2025
News · 02/05/2025

In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.

READ MORE
Technologies And Strategies Reshaping Regulatory Trends
News · 02/05/2025

The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.

READ MORE
Biomanufacturing proliferates in chemicals
News · 31/03/2025

In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?

READ MORE
New Trump tariffs worry North American chemical industries
News · 31/03/2025

High duties on imports from Canada, Mexico and China raise problems for international supply chains.

READ MORE